Replies to post #125942 on Biotech Values

[NP1986]

There have also been CR's reported with Abraxane.

An Abraxane/gemcitabine combo study had three CRs (4%):
http://www.medicalnewstoday.com/releases/185903.php

So yes, it would make interpreting the results of the single-arm study difficult - unless the results are overwhelming.